(en) Nicholas Mitsiades, Wei-hsuan Yu, Vassiliki Poulaki, Maria Tsokos et Ivan Stamenkovic, « Matrix Metalloproteinase-7-mediated Cleavage of Fas Ligand Protects Tumor Cells from Chemotherapeutic Drug Cytotoxicity », Cancer Research, vol. 61, no 2, , p. 577-581 (PMID11212252, lire en ligne)
(en) Qingshan Fu, Tian-Min Fu, Anthony C. Cruz, Prabuddha Sengupta, Stacy K. Thomas, Shuqing Wang, Richard M. Siegel, Hao Wu et James J. Chou, « Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor », Molecular Cell, vol. 61, no 4, , p. 602-613 (PMID26853147, PMCID4761300, DOI10.1016/j.molcel.2016.01.009, lire en ligne)
(en) Thomas S. Griffith, Thomas Brunner, Sharon M. Fletcher, Douglas R. Green et Thomas A. Ferguson, « Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege », Science, vol. 270, no 5239, , p. 1189-1192 (PMID7502042, DOI10.1126/science.270.5239.1189, JSTOR2889221, lire en ligne)
(en) Magdalena Szarynska, Agata Olejniczak, Piotr Wierzbicki, Jaroslaw Kobiela, Dariusz Laski, Zbigniew Sledzinski, Krystian Adrych, Marek Guzek et Zbigniew Kmiec, « FasR and FasL in colorectal cancer », International Journal of Oncology, vol. 51, no 3, , p. 975-986 (PMID28766682, DOI10.3892/ijo.2017.4083, lire en ligne)
(en) Qingshan Fu, Tian-Min Fu, Anthony C. Cruz, Prabuddha Sengupta, Stacy K. Thomas, Shuqing Wang, Richard M. Siegel, Hao Wu et James J. Chou, « Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor », Molecular Cell, vol. 61, no 4, , p. 602-613 (PMID26853147, PMCID4761300, DOI10.1016/j.molcel.2016.01.009, lire en ligne)
(en) Thomas S. Griffith, Thomas Brunner, Sharon M. Fletcher, Douglas R. Green et Thomas A. Ferguson, « Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege », Science, vol. 270, no 5239, , p. 1189-1192 (PMID7502042, DOI10.1126/science.270.5239.1189, JSTOR2889221, lire en ligne)
(en) Thomas S. Griffith, Thomas Brunner, Sharon M. Fletcher, Douglas R. Green et Thomas A. Ferguson, « Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege », Science, vol. 270, no 5239, , p. 1189-1192 (PMID7502042, DOI10.1126/science.270.5239.1189, JSTOR2889221, lire en ligne)
(en) Magdalena Szarynska, Agata Olejniczak, Piotr Wierzbicki, Jaroslaw Kobiela, Dariusz Laski, Zbigniew Sledzinski, Krystian Adrych, Marek Guzek et Zbigniew Kmiec, « FasR and FasL in colorectal cancer », International Journal of Oncology, vol. 51, no 3, , p. 975-986 (PMID28766682, DOI10.3892/ijo.2017.4083, lire en ligne)
(en) Qingshan Fu, Tian-Min Fu, Anthony C. Cruz, Prabuddha Sengupta, Stacy K. Thomas, Shuqing Wang, Richard M. Siegel, Hao Wu et James J. Chou, « Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor », Molecular Cell, vol. 61, no 4, , p. 602-613 (PMID26853147, PMCID4761300, DOI10.1016/j.molcel.2016.01.009, lire en ligne)
(en) Nicholas Mitsiades, Wei-hsuan Yu, Vassiliki Poulaki, Maria Tsokos et Ivan Stamenkovic, « Matrix Metalloproteinase-7-mediated Cleavage of Fas Ligand Protects Tumor Cells from Chemotherapeutic Drug Cytotoxicity », Cancer Research, vol. 61, no 2, , p. 577-581 (PMID11212252, lire en ligne)
(en) Thomas S. Griffith, Thomas Brunner, Sharon M. Fletcher, Douglas R. Green et Thomas A. Ferguson, « Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege », Science, vol. 270, no 5239, , p. 1189-1192 (PMID7502042, DOI10.1126/science.270.5239.1189, JSTOR2889221, lire en ligne)
spandidos-publications.com
(en) Magdalena Szarynska, Agata Olejniczak, Piotr Wierzbicki, Jaroslaw Kobiela, Dariusz Laski, Zbigniew Sledzinski, Krystian Adrych, Marek Guzek et Zbigniew Kmiec, « FasR and FasL in colorectal cancer », International Journal of Oncology, vol. 51, no 3, , p. 975-986 (PMID28766682, DOI10.3892/ijo.2017.4083, lire en ligne)